GenapSys

📍 Redwood City, United States🗓 Founded 2010👥 89 employees💰 Last funded Mar 2013
Biotechnology🌐 GenapSys.com
Website LinkedIn
At GenapSys we are working to power the world of healthcare and diagnostics with advanced DNA sequencing technology. Our sequencing instrument platform leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors, enabling a wide range of applications including targeted sequencing in oncology, pharmacogenomics and genome-wide sequencing in microbiology and others. We believe in a world where every researcher has a compact, scalable, and affordable sequencer in their own lab, empowering the democratization of genetic sequencing. Our novel sequencing method is revolutionizing genomics discovery, biomedical research, healthcare, diagnostics, agriculture, and a variety of other fields. Our team brings together an incredibly diverse and multidisciplinary set of backgrounds and skills – from electrical and mechanical engineers, physicists, chemists, microfluidic engineers, molecular biologists, bioinformaticians, mathematicians and more. It is a super exciting time to join GenapSys as we recently launched our first product which is generating a tremendous amount of interest.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2010
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
China
1
Frequently asked questions
Who invested in GenapSys?
GenapSys has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did GenapSys last raise funding?
The most recent investment in GenapSys recorded on gritt.io was in March 2013.
When was GenapSys founded?
GenapSys was founded in 2010.
What industry is GenapSys in?
GenapSys operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is GenapSys based?
GenapSys is headquartered in Redwood City, United States.